Ask Us
Register
Monitoring Medicines for over 2,572,000 Members
Australia
Brasil
Deutschland
España
France
United Kingdom
United States
English
Español
What is MediGuard?
Drugs A to Z
Conditions
Research
About Us
Recent Pages:
Microbid satisfaction and usage data | Monitoring more than 3,800 patients | Drug safety information
/
Bystolic satisfaction and usage data | Monitoring more than 2,100 patients | Drug safety information
/
Depakote satisfaction and usage data | Monitoring more than 16,000 patients | Drug safety information
Please correct the highlighted fields below.
Alerts for
Methylphenidate
Title
Date Published
Source
FDA Issues Safety Review Update of Medications Used to Treat Attention-Deficit/Hyperactivity Disorder (ADHD)
2011-11-02
Non-Safety-Related Recall of Several Lots of Daytrana Patches
2011-07-21
Delay in Results From FDA's Ongoing Safety Review of Stimulant Medications used in Children with ADHD
2010-08-05
Additional List of Recalled Lots of Daytrana Patches Published By FDA
2010-06-11
Non-Safety-Related Recall of a Limited Portion of Daytrana Patches
2010-04-02
MHRA Review of METHYLPHENIDATE and Risk of Genetic Damage and Update to Patient Information Leaflet
2010-02-15
Ongoing FDA Safety Review of Stimulant Mediations Used to Treat ADHD in Children
2009-06-16
Several lots of DAYTRANA (methylphenidate transdermal system) Voluntarily Recalled
2009-03-20
Risk of Burns during MRI Scans from Transdermal Drug Patches with Metallic Backings
2009-03-09
Several lots of DAYTRANA (methylphenidate transdermal system) voluntarily recalled
2008-08-26
See alerts for all drugs